Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-498-5353
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1990 - 1993- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1987 - 1989
Stanford University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1989 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Start of enrollment: 2012 Dec 01
- Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) Start of enrollment: 2013 Sep 01
- Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody Start of enrollment: 2014 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 904 citationsPD-1 Blockade in Tumors with Mismatch-Repair Deficiency.Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling
The New England Journal of Medicine. 2015-06-25 - 419 citationsNCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.George D. Demetri, Robert S. Benjamin, Charles D. Blanke, Jean-Yves Blay, Paolo G. Casali
Journal of the National Comprehensive Cancer Network. 2007-07-01 - 191 citationsPhase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.Anne M. Yahanda, K M Alder, George A. Fisher, N A Brophy, Joanne Halsey
Journal of Clinical Oncology. 1992-10-01
Lectures
- A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Using Molecular Diagnostics Across the Cancer Care Continuum to Enhance the Care of Esophageal and Gastric CancerASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- 9th Annual Meeting of International Society of Gastrointestinal OncologyInternational Society of Gastrointestinal Oncology (ISGIO), Arlington, Virginia - 9/13/2012
Press Mentions
George Hahn, Radiation Biologist Who Pioneered Heat Treatment for Cancer, Dies at 98June 5th, 2024- Immunotherapy Before Surgery Leads to Better Outcomes for People with Colon CancerJune 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
